LNSR Q3 2024 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+38.2% YoY

Gross Profit

$6M46.3% margin

Operating Income

-$1M-7.5% margin

Net Income

-$2M-11.1% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+7.1%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$668,000

Balance Sheet

Total Assets

$62M

Total Liabilities

$39M

Stockholders' Equity

$23M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$10M	+38.2%
Gross Profit	$6M	$5M	+28.5%
Operating Income	-$1M	-$2M	+50.3%
Net Income	-$2M	$3M	-158.5%

Revenue Segments

Product

$11M90%

Service

$1M10%

Geographic Segments

UNITED STATES

$6M52%

Europe

$4M30%

Asia Excluding South Korea

$2M17%

KOREA, REPUBLIC OF

$145,0001%

Other Geographical Region

$63,0001%